Abstract

P2.08 Osimertinib for Metastatic, EGFR Mutated Non-small Cell Lung Cancer. Real World Evidence at National Oncology Institute, Panama

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call